TiGenix : announcement FY 2011 results

Regulated information March 8, 2012 TiGenix to announce 2011 results on March 15 Leuven (BELGIUM) - March 8, 2012 - TiGenix (NYSE Euronext: TIG) announced today the Company will issue its full-year 2011 results at 7:00 CET on March 15, followed by a discussion of the results and a business update in a conference call at 15:00 CET. Title:                     TiGenix Full-Year 2011 Financial Results Date:                    March 15, 2012 Time:                    15:00 CET (14:00 GMT/9:00 EST) To participate, please listen to the webcast or call one of the following telephone numbers. International dial-in numbers:                         +32 2 620 0138                      Belgium                         +34 91 791 7146                    Spain                         +31 20 721 9158                    Netherlands                         +44 20 3106 4822                  UK                         +1 646 254 3388                    USA For more information: Hans Herklots Director Investor & Media Relations hans.herklots@tigenix.com +32 16 39 79 73 About TiGenix TiGenix NV (NYSE Euronext Brussels: TIG) is a leading European cell therapy company with two marketed products for cartilage repair, and a strong pipeline with clinical stage allogeneic adult stem cell programs for the treatment of autoimmune and inflammatory diseases. TiGenix is based out of Leuven (Belgium) and has operations in Madrid (Spain), Cambridge (UK) and Sittard- Geleen (the Netherlands). For more information please visit www.tigenix.com. This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that: (i) the releases contained herein are protected by copyright and other applicable laws; and (ii) they are solely responsible for the content, accuracy and originality of the information contained therein. Source: TiGenix via Thomson Reuters ONE [HUG#1592386]